These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37441365)

  • 1. Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan.
    Sorano S; Procter SR; Seale AC
    Vaccine X; 2023 Aug; 14():100332. PubMed ID: 37441365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of maternal immunization against neonatal invasive Group B Streptococcus in the Netherlands.
    Hahn BA; de Gier B; van Kassel MN; Bijlsma MW; van Leeuwen E; Wouters MGAJ; van der Ende A; van de Beek D; Wallinga J; Hahné SJM; Jan van Hoek A
    Vaccine; 2021 May; 39(21):2876-2885. PubMed ID: 33895018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
    Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
    Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
    Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
    Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
    Procter SR; Gonçalves BP; Paul P; Chandna J; Seedat F; Koukounari A; Hutubessy R; Trotter C; Lawn JE; Jit M
    PLoS Med; 2023 Mar; 20(3):e1004068. PubMed ID: 36917564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
    Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
    Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.
    Russell LB; Kim SY; Cosgriff B; Pentakota SR; Schrag SJ; Sobanjo-Ter Meulen A; Verani JR; Sinha A
    Vaccine; 2017 Dec; 35(49 Pt B):6905-6914. PubMed ID: 29129451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    Schrag SJ; Verani JR
    Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.
    Seale AC; Bianchi-Jassir F; Russell NJ; Kohli-Lynch M; Tann CJ; Hall J; Madrid L; Blencowe H; Cousens S; Baker CJ; Bartlett L; Cutland C; Gravett MG; Heath PT; Ip M; Le Doare K; Madhi SA; Rubens CE; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J; Lawn JE
    Clin Infect Dis; 2017 Nov; 65(suppl_2):S200-S219. PubMed ID: 29117332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.
    Colbourn T; Asseburg C; Bojke L; Philips Z; Claxton K; Ades AE; Gilbert RE
    Health Technol Assess; 2007 Aug; 11(29):1-226, iii. PubMed ID: 17651659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden.
    Gonçalves BP; Procter SR; Paul P; Chandna J; Lewin A; Seedat F; Koukounari A; Dangor Z; Leahy S; Santhanam S; John HB; Bramugy J; Bardají A; Abubakar A; Nasambu C; Libster R; Sánchez Yanotti C; Horváth-Puhó E; Sørensen HT; van de Beek D; Bijlsma MW; Gardner WM; Kassebaum N; Trotter C; Bassat Q; Madhi SA; Lambach P; Jit M; Lawn JE; ; ; ;
    Lancet Glob Health; 2022 Jun; 10(6):e807-e819. PubMed ID: 35490693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention.
    Paul P; Gonçalves BP; Le Doare K; Lawn JE
    Curr Opin Pediatr; 2023 Apr; 35(2):223-230. PubMed ID: 36749143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
    Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
    Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.
    Mohle-Boetani JC; Schuchat A; Plikaytis BD; Smith JD; Broome CV
    JAMA; 1993 Sep 22-29; 270(12):1442-8. PubMed ID: 8371444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapartum antibiotics for known maternal Group B streptococcal colonization.
    Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007467. PubMed ID: 23440815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapartum antibiotics for known maternal Group B streptococcal colonization.
    Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007467. PubMed ID: 19588432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan.
    Hoshi SL; Seposo X; Okubo I; Kondo M
    Vaccine; 2018 Aug; 36(34):5133-5140. PubMed ID: 30041878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.